The Guest Editorial by Sullivan 1 on DISC1 reflects not only his limitations in understanding biology, but more broadly reflects those of a group of statistically trained non-biologists who are currently very active (and vocal) in psychiatric genetics. Illness works through alterations in biology. Biology works at a gene level and not at a single-nucleotide polymorphism (SNP) level. Biologically important genes such as DISC1 (or BDNF or COMT) have more SNP heterogeneity and diversity in the population 2 likely owing to the need to evolutionarily adapt and fine-tune the interface between organism and environment. 3 Integrative approaches at a gene level clearly demonstrate their involvement and show reproducibility 4 as opposed to the statistically driven SNP-focused Genome-Wide Association Study (GWAS) approaches of Sullivan and colleagues 5 that have identified primarily housekeeping genes to date (such as ANK3, CACNA1C and ODZ). In fact, SNP-focused GWAS approaches miss the boat on their own data. The overlap between GWAS studies is 100-fold greater at a gene level than at a nominally significant SNP level 4 . Moreover, what non-biologists do not understand is how the brain (or for the matter, the body) works. Schizophrenia, like other complex disorders, is a broad entity overlapping with other disorders. Genes and their products are building blocks that in different combinations, and in different environmental contexts, give different psychiatric and non-psychiatric syndromes. In the sporting tradition of years past in science, before things became rather boring and politically correct, I would like to wager with Sullivan 1 the following: whomever is wrong between the two of us on this subject should write a Letter to Molecular Psychiatry in 2020, titled Mea Culpa on DISC1.
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The author declares no conflict of interest. A 10-point visual analog scale (VAS), ranging from 1 (no craving) to 10 (intense craving) was used to estimate the patients' subjective level of craving. 5 Levomethadone (patient-blinded administration) was gradually reduced if VASo5 until tapered off completely (Figure 1 ), without resulting in increased craving for levomethadone or heroin, respectively (Figure 1) . Although previous replacement treatments were not able to lastingly prevent heroin abuse, both patients, except for one singular incident of heroin consumption a few weeks after surgery, remained lastingly off heroin and levomethadone. Patients reported that this singular consumption was solely motivated by mere curiosity and that the psychotropic effect was perceived as clearly alleviated and did not reinstate chronic heroin abuse, as was confirmed by urine analyses.
AB Niculescu III
In line with previous findings from DBS in depression 6 accumbal stimulation led to an amelioration of the patients' depressive and anxious symptoms, as well as an increase of the subjectively perceived quality of life (Figure 1 ). Both patients still reported the occasional consumption of other psychotropic substances arising out of boredom or coexisting private and occupational strains with at the same time lacking alternative behavioral patterns and compensatory social skills.
Recent findings from animal studies indicate that psychotropic substances (for example, cocaine) promote rather immediate changes of synaptic plasticity in D1-expressing accumbal neurons, which can be reversed by inhibitory optogenetic stimulation of
